Perceptive Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,441,700
| Closed | -$43.4M | – | 137 |
|
|
2018
Q3 | $43.4M | Buy |
2,441,700
+520,000
| +27% | +$9.24M | 1.16% | 27 |
|
|
2018
Q2 | $26.5M | Sell |
1,921,700
-280,000
| -13% | -$3.86M | 0.7% | 39 |
|
|
2018
Q1 | $20M | Buy |
2,201,700
+750,000
| +52% | +$6.82M | 0.56% | 46 |
|
|
2017
Q4 | $6.21M | Buy |
+1,451,700
| New | +$6.21M | 0.21% | 71 |
|
|
2014
Q2 | – | Sell |
-435,000
| Closed | -$10.4M | – | 152 |
|
|
2014
Q1 | $10.4M | Sell |
435,000
-236,300
| -35% | -$5.63M | 1.09% | 28 |
|
|
2013
Q4 | $5.23M | Buy |
671,300
+252,585
| +60% | +$1.97M | 0.63% | 36 |
|
|
2013
Q3 | $5.58M | Buy |
418,715
+349,909
| +509% | +$4.66M | 0.45% | 35 |
|
|
2013
Q2 | $903K | Buy |
+68,806
| New | +$903K | 0.09% | 51 |
|